UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934

 

Date of Report (Date of earliest event reported) November 11, 2004

 


 

AGILENT TECHNOLOGIES, INC.

(Exact name of registrant as specified in its charter)

 


 

Delaware   001-15405   77-0518772

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

395 Page Mill Road, Palo Alto, California 94306

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code (650) 752-5000

 

 

(Former name, former address and former fiscal year, if changed since last report)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240-14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Item 2.02 Results of Operations and Financial Condition

 

The information in this Item 2.02 of Form 8-K and Exhibit 99.1 attached hereto is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.

 

On November 11, 2004, Agilent Technologies, Inc. (the “Company”) issued its press release announcing financial results for the three months ended October 31, 2004. A copy of this press release is attached as Exhibit 99.1.

 

We provide non-GAAP financial information in order to provide meaningful supplemental information regarding our operational performance and to enhance our investors’ overall understanding of our core current financial performance and our prospects for the future. We believe that our investors benefit from seeing our results “through the eyes” of management in addition to the GAAP presentation. Management measures segment and enterprise performance using measures such as those that are disclosed in this release. This information facilitates management’s internal comparisons to the company’s historical operating results and comparisons to competitors’ operating results. Non-GAAP information allows for greater transparency to supplemental information used by management in its financial and operational decision making. Historically, we have reported similar non-GAAP information to our investors and believe that the inclusion of comparative numbers provides consistency in our financial reporting.

 

This information is not in accordance with, or an alternative for, generally accepted accounting principles in the United States. It excludes items, such as restructuring and amortization, that may have a material effect on the company’s earnings and earnings per share calculated in accordance with GAAP. Management monitors these items to ensure that expenses are in line with expectations and that our GAAP results are correctly stated but does not use them to measure the ongoing operating performance of the company. The non-GAAP information we provide may be different from the non-GAAP information provided by other companies.


Item 8.01 Other Events

 

The Company grants various awards to its executive officers under the Agilent Technologies, Inc. 1999 Stock Plan, as amended and restated (the “Plan”). Forms of Award Agreements under the Plan are attached hereto as exhibits and are hereby incorporated by reference. The Company also grants stock options to its directors under the Agilent Technologies, Inc. 1999 Non-Employee Director Stock Plan, as amended and restated (the “Director Plan”). A form of agreement under the Director Plan is attached hereto as an exhibit and is hereby incorporated by reference.


Item 9.01 Financial Statements and Exhibits

 

(c) Exhibits

 

The following are filed as exhibits to this report:

 

10.1: Form of Award Agreement (U.S.) for grants under the Agilent Technologies, Inc. 1999 Stock Plan.

 

10.2: Form of Award Agreement (Non-U.S.) for grants under the Agilent Technologies, Inc. 1999 Stock Plan.

 

10.3: Form of Stock Option Agreement for grants under the Agilent Technologies, Inc. 1999 Non-Employee Director Stock Plan.

 

The following is furnished as an exhibit to this report, and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended:

 

99.1 Press release announcing financial results for three months ended October 31, 2004.


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

AGILENT TECHNOLOGIES, INC.

By:  

/s/    Marie Oh Huber


Name:

  Marie Oh Huber
Title:   Vice President, Assistant Secretary and
    Assistant General Counsel

 

Date: November 12, 2004


EXHIBIT INDEX

 

Exhibit No.

 

Description


10.1   Form of Award Agreement (U.S.) for grants under the Agilent Technologies, Inc. 1999 Stock Plan.
10.2   Form of Award Agreement (Non-U.S.) for grants under the Agilent Technologies, Inc. 1999 Stock Plan.
10.3   Form of Stock Option Agreement for grants under the Agilent Technologies, Inc. 1999 Non-Employee Director Stock Plan.
99.1   Press release announcing financial results for three months ended October 31, 2004.

Exhibit 10.1

 

FORM OF AGILENT TECHNOLOGIES, INC.

1999 STOCK PLAN

AWARD AGREEMENT (NON-QUALIFIED)

 

THIS AGREEMENT, dated as of the date of grant indicated in your Smith Barney account the (“Grant Date”) between Agilent Technologies, Inc., a Delaware corporation (the “Company”), and you as an individual who has been granted a stock option pursuant to the Agilent Technologies, Inc. 1999 Stock Plan (the “Awardee”) is entered into as follows:

 

WITNESSETH:

 

WHEREAS, the Company has established the Agilent Technologies, Inc. 1999 Stock Plan, as amended and restated effective November 18, 2003, (the “Plan”), and a description of the terms and conditions of the Plan is set forth in the U.S. Plan prospectus (the “Prospectus”). A copy of the Prospectus is available at http://stockoptions.corporate.agilent.com and also on your Smith Barney website. A copy of the Plan document can be viewed at http://stockoptions.corporate.agilent.com and will also be made available upon request; and

 

WHEREAS, the Compensation Committee of the Board of Directors of the Company (the “Committee”) or its authorized delegate(s) determined that the Awardee shall be granted an option under the Plan as hereinafter set forth;

 

NOW THEREFORE, the parties hereby agree that the Company grants the Awardee an option (“Option”) to purchase the number of shares of the Company’s $0.01 par value voting common stock indicated in the Awardee’s Smith Barney account.

 

1. This Option is granted under and pursuant to the Plan and is subject to each and all of the provisions thereof. In the event of a conflict between the terms and conditions of the Plan and the terms and conditions of this Award Agreement, the terms and conditions of the Plan shall prevail.

 

2. The Option price shall be equal to the Fair Market Value (as defined in the Plan document) of the underlying shares on the Grant Date. The Option price for this grant is indicated in the Awardee’s Smith Barney account.

 

3. This Option is not transferable by the Awardee except by will or the laws of descent and distribution. During the Awardee’s lifetime, only the Awardee can exercise this Option. This Option may not be transferred, assigned, pledged or hypothecated by the Awardee during his or her lifetime, whether by operation of law or otherwise, and is not subject to execution, attachment or similar process.

 

4. Subject to accelerated vesting upon the occurrence of certain events as set forth in the Plan, and so long as the Awardee retains status as an Awardee Eligible to Vest as such term is defined in the Plan, this Option will vest in whole or in part, in accordance with the following vesting schedule:

 

An Awardee loses status as an Awardee Eligible to Vest when certain events occur, including but not limited to, termination of employment with the Company or transfer of employment from the Company.

 

5. This Option will expire ten (10) years from the Grant Date, unless sooner terminated, forfeited, or canceled in accordance with the provisions of the Plan. This means that the Option must be exercised, if at all, on or before the expiration date. This expiration date is indicated in the Awardee’s Smith Barney account. The Awardee is responsible for keeping track of this date and will not receive any prior notification of the expiration date from the Company.

 

6. As set forth in the Prospectus, this Option may be exercised by following the steps indicated in the Awardee’s Smith Barney account. In addition, Smith Barney must receive an executed authorization form accompanied by payment of the full Option price for the underlying shares, including applicable taxes. Payment may be in cash or shares of the Company’s Common Stock or a combination thereof, provided, however, that any payment in shares shall be in strict compliance with all procedural rules established by the Committee or its authorized delegate(s). In some instances, the Committee or its authorized delegate(s) may also permit payment using a cashless method of exercise. The Company reserves the right to limit availability of certain methods of exercise as it deems necessary.

 

7. All rights of the Awardee in this Option, to the extent that it has not vested, shall terminate when Awardee loses status as an Awardee Eligible to Vest, except where such status is lost due to the occurrence of certain events as set forth in the Plan. For example, if status as an Awardee Eligible to Vest is lost because of death, retirement due to age or permanent and total disability, the vesting of unvested Awards will accelerate.


All rights of the Awardee in this Option, to the extent that it has vested but has not been exercised, shall terminate on the earlier of the expiration date or three (3) months after the Awardee loses status as an Awardee Eligible to Vest, except where the Awardee loses such status because of death, retirement due to age or permanent and total disability. In the event of the Awardee’s death, his or her legal representative or designated beneficiary shall have the right to exercise all or a portion of the Awardee’s right under this Option. The representative or designee must exercise the Option before the earlier of the expiration date or one (1) year after the death of the Awardee, and shall be bound by the provisions of the Plan. In case of retirement due to age or permanent and total disability, the Awardee retains rights in this Option until the earlier of the expiration date or three (3) years from the date thereof.

 

8. The Awardee shall remit to the Company payment for all applicable withholding taxes and required social security contributions at the time the Awardee exercises any portion of this Option.

 

9. By accepting the grant of this Option, Awardee acknowledges and agrees that: (i) the Plan is discretionary in nature and may be suspended or terminated by the Company at any time; (ii) the grant of an option is a one-time benefit which does not create any contractual or other right to receive future grants of options, or benefits in lieu of options; (iii) all determinations with respect to any such future grants, including, but not limited to, the times when options shall be granted, the maximum number of shares subject to each option and the option price, will be at the sole discretion of the Company; (iv) participation in the Plan is voluntary; (v) the value of the option is outside the scope of Awardee’s employment contract, if any; (vi) the value of the option is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments; (vii) the vesting of any Option ceases upon termination of employment with the Company or transfer of employment from the Company, or other cessation of eligibility to vest for any reason, except as may otherwise be explicitly provided in the Plan document or this Agreement; (viii) if the underlying stock does not increase in value, this Option will have no value, nor does the Company guarantee any future value; (ix) no claim or entitlement to compensation or damages arises if the Option does not increase in value and Awardee irrevocably releases the Company and its subsidiaries from any such claim that does arise.

 

10. For the exclusive purpose of implementing, administering and managing Awardee’s stock options, Awardee consents to the collection, receipt, use, retention and transfer, in electronic or other form, of his or her personal data by and among the Company, its subsidiaries, affiliates and third party vendors. Awardee understands that personal data, including but not limited to, name, home address, telephone number, employee number, employment status, social security number, tax identification number, job and payroll location, data for tax withholding purposes and shares of stocks awarded, cancelled, exercised, vested and unvested may be transferred to third parties assisting in the implementation, administration and management of Awardee’s stock options and Awardee expressly authorizes such transfer as well as the retention, use, and the subsequent transfer of the data by the recipient(s). Awardee understands that these recipients may be located in Awardee’s country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than Awardee’s country. Awardee understands that data will be held only as long as is necessary to implement, administer and manage Awardee’s stock option. Awardee understands that he or she may, at any time, request a list with the names and addresses of any potential recipients of the personal data, view data, request additional information about the storage and processing of data, require any necessary amendments to data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Company’s legal department representative. Awardee understands, however, that refusing or withdrawing his or her consent may affect his or her ability to accept an Award under the Plan. For more information on the consequences of Awardee’s refusal to consent or withdrawal of consent, Awardee may contact the Company’s local legal department representative.

 

11. The Plan is incorporated herein by reference. The Plan and this Award Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Optionee with respect to the subject matter hereof, and may not be modified adversely to the Awardee’s interest except by means of a writing signed by the Company and the Awardee. This agreement is governed by the internal substantive laws, but not the choice of law rules, of the state of Delaware. Any proceeding arising out of or relating to this Award Agreement or the Plan may be brought only in the state or federal courts located in the Northern District of California.

 

12. Neither the Plan nor this Award Agreement nor any provision under either shall be construed so as to grant the Awardee any right to remain in the employ of the Company or any of its subsidiaries, and it is expressly agreed and understood that employment is terminable at the will of either party.

 

13. By accepting the grant of this Option evidenced hereby, the Awardee and the Company agree that this Option is granted under and governed by the terms and conditions of the Plan and this Award Agreement. Awardee has reviewed the Prospectus and this Award Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to accepting the Option and fully understands all provisions of the Prospectus and Award Agreement. Awardee agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions relating to the Plan and Award Agreement.


14. The Awardee acknowledges that this Award Agreement is between the Awardee and the Company, and that the Awardee’s local employer is not a party to this Award Agreement.

 

15. The Awardee acknowledges that he or she may be executing part or all of the Award Agreement in English and agrees to be bound accordingly.

 

16. The Awardee acknowledges that by clicking on the “Accept” button on the screen titled “Step 3: Confirm the Review/Acceptance of your Award,” the Awardee agrees to be bound by the electronic execution of this Award Agreement.

 

Agilent Technologies, Inc.

By  

 


    Edward W. Barnholt
    President, Chief Executive Officer and Director
By  

 


    D. Craig Nordlund
    Senior Vice President, General Counsel and Secretary

 

PLEASE PRINT AND KEEP A COPY FOR YOUR RECORDS

Exhibit 10.2

 

FORM OF AGILENT TECHNOLOGIES, INC.

1999 STOCK PLAN

AWARD AGREEMENT

 

THIS AGREEMENT, dated as of the date of grant indicated in your Smith Barney account the (“Grant Date”) between Agilent Technologies, Inc., a Delaware corporation (the “Company”), and you as an individual who has been granted a stock option pursuant to the Agilent Technologies, Inc. 1999 Stock Plan (the “Awardee”) is entered into as follows:

 

WITNESSETH:

 

WHEREAS, the Company has established the Agilent Technologies, Inc. 1999 Stock Plan, as amended and restated effective November 18, 2003, (the “Plan”), and a description of the terms and conditions of the Plan is set forth in the U.S. Plan prospectus (the “Prospectus”). A copy of the Prospectus is available at http://stockoptions.corporate.agilent.com and also on your Smith Barney website. A copy of the Plan document can be viewed at http://stockoptions.corporate.agilent.com and will also be made available upon request; and

 

WHEREAS, the Compensation Committee of the Board of Directors of the Company (the “Committee”) or its authorized delegate(s) determined that the Awardee shall be granted an option under the Plan as hereinafter set forth;

 

NOW THEREFORE, the parties hereby agree that the Company grants the Awardee an option (“Option”) to purchase the number of shares of the Company’s $0.01 par value voting common stock indicated in the Awardee’s Smith Barney account.

 

  1. This Option is granted under and pursuant to the Plan and is subject to each and all of the provisions thereof. In the event of a conflict between the terms and conditions of the Plan and the terms and conditions of this Award Agreement, the terms and conditions of the Plan shall prevail.

 

  2. The Option price shall be equal to the Fair Market Value (as defined in the Plan document) of the underlying shares on the Grant Date. The Option price for this grant is indicated in the Awardee’s Smith Barney account.

 

  3. This Option is not transferable by the Awardee except by will or the laws of descent and distribution. During the Awardee’s lifetime, only the Awardee can exercise this Option. This Option may not be transferred, assigned, pledged or hypothecated by the Awardee during his or her lifetime, whether by operation of law or otherwise, and is not subject to execution, attachment or similar process.

 

  4. Subject to accelerated vesting upon the occurrence of certain events as set forth in the Plan, and so long as the Awardee retains status as an Awardee Eligible to Vest as such term is defined in the Plan, this Option will vest in whole or in part, in accordance with the following vesting schedule:

 

An Awardee loses status as an Awardee Eligible to Vest when certain events occur, including but not limited to, termination of employment with the Company or transfer of employment from the Company.

 

  5. This Option will expire ten (10) years from the Grant Date, unless sooner terminated, forfeited, or canceled in accordance with the provisions of the Plan. This means that the Option must be exercised, if at all, on or before the expiration date. This expiration date is indicated in the Awardee’s Smith Barney account. The Awardee is responsible for keeping track of this date and will not receive any prior notification of the expiration date from the Company.

 

  6. As set forth in the Prospectus, this Option may be exercised by following the steps indicated in the Awardee’s Smith Barney account. In addition, Smith Barney must receive an executed authorization form accompanied by payment of the full Option price for the underlying shares, including applicable taxes. Payment may be in cash or shares of the Company’s Common Stock or a combination thereof, provided, however, that any payment in shares shall be in strict compliance with all procedural rules established by the Committee or its authorized delegate(s). In some instances, the Committee or its authorized delegate(s) may also permit payment using a cashless method of exercise. The Company reserves the right to limit availability of certain methods of exercise as it deems necessary.

 

  7. All rights of the Awardee in this Option, to the extent that it has not vested, shall terminate when Awardee loses status as an Awardee Eligible to Vest, except where such status is lost due to the occurrence of certain events as set forth in the Plan. For example, if status as an Awardee Eligible to Vest is lost because of death, retirement due to age or permanent and total disability, the vesting of unvested Awards will accelerate.


All rights of the Awardee in this Option, to the extent that it has vested but has not been exercised, shall terminate on the earlier of the expiration date or three (3) months after the Awardee loses status as an Awardee Eligible to Vest, except where the Awardee loses such status because of death, retirement due to age or permanent and total disability. In the event of the Awardee’s death, his or her legal representative or designated beneficiary shall have the right to exercise all or a portion of the Awardee’s right under this Option. The representative or designee must exercise the Option before the earlier of the expiration date or one (1) year after the death of the Awardee, and shall be bound by the provisions of the Plan. In case of retirement due to age or permanent and total disability, the Awardee retains rights in this Option until the earlier of the expiration date or three (3) years from the date thereof.

 

  8. The Awardee shall remit to the Company payment for all applicable withholding taxes and required social security contributions at the time the Awardee exercises any portion of this Option.

 

  9. By accepting the grant of this Option, Awardee acknowledges and agrees that: (i) the Plan is discretionary in nature and may be suspended or terminated by the Company at any time; (ii) the grant of an option is a one-time benefit which does not create any contractual or other right to receive future grants of options, or benefits in lieu of options; (iii) all determinations with respect to any such future grants, including, but not limited to, the times when options shall be granted, the maximum number of shares subject to each option and the option price, will be at the sole discretion of the Company; (iv) participation in the Plan is voluntary; (v) the value of the option is outside the scope of Awardee’s employment contract, if any; (vi) the value of the option is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments; (vii) the vesting of any Option ceases upon termination of employment with the Company or transfer of employment from the Company, or other cessation of eligibility to vest for any reason, except as may otherwise be explicitly provided in the Plan document or this Agreement; (viii) if the underlying stock does not increase in value, this Option will have no value, nor does the Company guarantee any future value; (ix) no claim or entitlement to compensation or damages arises if the Option does not increase in value and Awardee irrevocably releases the Company and its subsidiaries from any such claim that does arise.

 

  10. For the exclusive purpose of implementing, administering and managing Awardee’s stock options, Awardee consents to the collection, receipt, use, retention and transfer, in electronic or other form, of his or her personal data by and among the Company, its subsidiaries, affiliates and third party vendors. Awardee understands that personal data, including but not limited to, name, home address, telephone number, employee number, employment status, social security number, tax identification number, job and payroll location, data for tax withholding purposes and shares of stocks awarded, cancelled, exercised, vested and unvested, may be transferred to third parties assisting in the implementation, administration and management of Awardee’s stock options and Awardee expressly authorizes such transfer as well as the retention, use, and the subsequent transfer of the data by the recipient(s). Awardee understands that these recipients may be located in Awardee’s country or elsewhere, and that the recipient’s country may have different data privacy laws and protections than Awardee’s country. Awardee understands that data will be held only as long as is necessary to implement, administer and manage Awardee’s stock option. Awardee understands that he or she may, at any time, request a list with the names and addresses of any potential recipients of the personal data, view data, request additional information about the storage and processing of data, require any necessary amendments to data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Company’s legal department representative. Awardee understands, however, that refusing or withdrawing his or her consent may affect his or her ability to accept an Award under the Plan. For more information on the consequences of Awardee’s refusal to consent or withdrawal of consent, Awardee may contact the Company’s local legal department representative.

 

  11. The Plan is incorporated herein by reference. The Plan and this Award Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Optionee with respect to the subject matter hereof, and may not be modified adversely to the Awardee’s interest except by means of a writing signed by the Company and the Awardee. This agreement is governed by the internal substantive laws, but not the choice of law rules, of the state of Delaware. Any proceeding arising out of or relating to this Award Agreement or the Plan may be brought only in the state or federal courts located in the Northern District of California.

 

  12. Neither the Plan nor this Award Agreement nor any provision under either shall be construed so as to grant the Awardee any right to remain in the employ of the Company or any of its subsidiaries, and it is expressly agreed and understood that employment is terminable at the will of either party.

 

  13. By accepting the grant of this Option evidenced hereby, the Awardee and the Company agree that this Option is granted under and governed by the terms and conditions of the Plan and this Award Agreement. Awardee has reviewed the Prospectus and this Award Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to accepting the Option and fully understands all provisions of the


Prospectus and Award Agreement. Awardee agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions relating to the Plan and Award Agreement.

 

  14. The Awardee acknowledges that this Award Agreement is between the Awardee and the Company, and that the Awardee’s local employer is not a party to this Award Agreement.

 

  15. The Awardee acknowledges that he or she may be executing part or all of the Award Agreement in English and agrees to be bound accordingly.

 

  16. The Awardee acknowledges that by clicking on the “Accept” button on the screen titled “Step 3: Confirm the Review/Acceptance of your Award,” the Awardee agrees to be bound by the electronic execution of this Award Agreement.

 

Agilent Technologies, Inc.

By

 

 


    Edward W. Barnholt
    President, Chief Executive Officer and Director

By

 

 


    D. Craig Nordlund
    Senior Vice President, General Counsel and Secretary

 

PLEASE PRINT AND KEEP A COPY FOR YOUR RECORDS

Exhibit 10.3

 

FORM OF AGILENT TECHNOLOGIES, INC

1999 NON-EMPLOYEE DIRECTOR STOCK PLAN

STOCK OPTION AGREEMENT

 

THIS AGREEMENT, dated                      (“Grant Date”) between AGILENT TECHNOLOGIES, INC., a Delaware corporation (“the Company”) and                      (“the Director”), a director of the Company is entered into as follows:

 

WITNESSETH:

 

WHEREAS, the Company has established the Agilent Technologies, Inc. 1999 Non-Employee Director Stock Plan (the “Plan”), a copy of which is attached hereto as Exhibit “A” and made a part hereof;

 

NOW THEREFORE, the parties hereby agree that in consideration of services to be rendered, the Company grants the Director an option (the “Option”) to purchase                  shares of Common Stock of the Company upon the terms and conditions set forth in the attached Plan document and further subject to the terms and conditions set forth herein.

 

1. The Option is granted under and pursuant to the Plan and is subject to each and all of the provisions thereof.

 

2. The exercise price of the Option shall be $          per share.

 

3. This Option is not transferable by the Director other than by will or the laws of descent and distribution, and is exercisable only by the Director during his or her lifetime. This Option may not be transferred, assigned, pledged, or hypothecated by the Director during his or her lifetime, whether by operation of law or otherwise, and is not subject to execution, attachment or similar process.

 

4. This Option may not be exercised before the first anniversary of the date hereof.

 

5. This Option will expire ten (10) years from the date hereof, unless sooner terminated or cancelled in accordance with the provisions of the Plan. Should the Director cease to be a member of the Board of Directors for any reason during the period commencing with the Grant Date hereof and ending on the next annual shareholders meeting (including, but not limited to, cessation by reason of the failure to be re-elected at such annual shareholders meeting), this Option shall be automatically cancelled on the date of such cessation.

 

6. This Option shall be exercised by delivering to the Secretary of the Company at its head office a written notice stating the number of shares as to which the Option is exercised. The written notice must be accompanied by payment of the full exercise price for such Option shares.

 

7. All rights of the Director in this Option, to the extent that it has not been exercised, shall terminate upon the death of the Director (except as hereinafter provided). The Director may, by written notice to the company, designate one or more persons, including his or her legal representative, who shall by reason of the Director’s death acquire the right to exercise all or a portion of the Director’s Option. The person so designated must exercise the Option within the term of the Option set forth in the attached document. The person designated to exercise the Option after the Director’s death shall be bound by the provisions of the Plan.

 

8. The Director hereby designates the following person(s) as the one(s) who may exercise this Option after his or her death as provided above:

 

Name:                                                                                                      Relationship:                                                                      
Name:                                                                                                      Relationship:                                                                      


The Director may change the above designation at his or her pleasure by filing with the Secretary of the Company a written notice of change.

 

IN WITNESS WHEREOF, the parties have executed this Agreement in duplicate the day and year first above written.

 

AGILENT TECHNOLOGIES, INC.
By:  

 


    Marie Oh Huber
    Vice President, Assistant Secretary and
    Assistant General Counsel

 

Accepted By:

 

 


    Director

 

RETAIN THIS AGREEMENT FOR YOUR RECORDS

Exhibit 99.1

 

EDITORIAL CONTACTS: PRGP42SN424

 

Michele Drake

+1 650 752 5296

michele_drake@agilent.com

 

Jorgen Tesselaar (Europe and Asia)

+31 20 547 2825

jorgen_tesselaar@agilent.com

 

INVESTOR CONTACT:

Hilliard Terry

+1 650 752 5329

hilliard_terry@agilent.com

 

Agilent Technologies Reports Fourth Quarter 2004 Results

 

PALO ALTO, Calif., Nov. 11, 2004 — Agilent Technologies Inc. (NYSE: A) today reported orders of $1.60 billion for the fourth fiscal quarter ended Oct. 31, 2004, 8 percent below one year ago. Revenues during the quarter were $1.82 billion, 9 percent ahead of last year. Fourth quarter GAAP net earnings were $74 million, or $0.15 per diluted share, compared to $13 million, or $0.03 per share, in last year’s fourth quarter.

 

Excluding $79 million of net restructuring and amortization charges, Agilent reported fourth quarter operating net income of $153 million, or $0.30 per share. On a comparable basis, the company earned $71 million, or $0.15 per share, one year ago.

 

For the full year 2004, Agilent achieved orders of $7.00 billion, up 15 percent from 2003, and revenues of $7.18 billion, up 19 percent from one year ago. This year, GAAP diluted earnings per share were $0.71, compared to a loss of $4.35 last year. Operating earnings (1) were $1.05 per share this year compared to a loss of $0.26 per share in 2003.

 

“Agilent continued to face a difficult environment in several of its key markets,” said Ned Barnholt, Agilent chairman, president and chief executive officer. “Compared to last quarter, however, our gross margins improved, operating expenses declined, working capital remained under good control and we generated $394 million in free cash flow (2) — despite $63 million lower revenues.”

 

Fourth quarter revenues, at $1.82 billion, were below company expectations because of weak conditions in semiconductor-related businesses. Operating earnings, at $0.30 per share, met the bottom of the company’s guidance range of $0.30 to $0.35 per share.

 

“For 2004 overall, we are pleased with Agilent’s performance despite the mixed finish,” Barnholt said. “During the year, we completed the company’s operational transformation that we began three years ago.”

 

From 2001 through 2004, Agilent reduced its operating breakeven by more than 35 percent, completely transformed its IT systems environment and reduced the number of IT applications by more than 75 percent, restored its Test and Measurement segment to traditional levels of profitability, and achieved both double-digit growth and double-digit operating margins in its Life Sciences and Chemical Analysis (LSCA) segment.

 

“Performance on the balance sheet has been strong, with inventory days-on-hand, receivables days sales outstanding and fixed investment all near historical lows,” Barnholt said. “As a result, Agilent has become consistently free-cash-flow positive (2) . During the past 12 months, we increased cash by over $700 million to more than $2.3 billion.”

 

Looking to fiscal 2005, the company said it expects the sharp adjustment in the semiconductor markets to continue to impact the performance of its Semiconductor Products and Automated Test segments for the next three to six months. Meanwhile, Test and Measurement growth is moderating because of slowing growth in mobile phone production. LSCA, on the other hand, shows few signs of slowing from its recent double-digit growth trend.


The company expects first quarter fiscal 2005 revenues of $1.60 billion to $1.70 billion and operating earnings of $0.14 to $0.21 per share (3) .

 

“Our commitment is to continue to manage costs and margins aggressively in the short term while maintaining investments critical to long-term market leadership and sustained creation of shareholder value,” Barnholt said.

 

Segment Results

 

Test and Measurement

(in millions)

 

     Q4:F04

   Q4:F03

    Q3:F04

Orders

   693    645     776

Revenues

   788    631     768

Operating Profit (4)

   116    (11 )   88

 

Fourth quarter Test and Measurement orders of $693 million were 7 percent above one year ago but down 11 percent from the third quarter. Overall segment demand was driven by seasonally strong aerospace and defense business and robust general-purpose markets, while weakness was concentrated in wireless handset manufacturing test. Revenues of $788 million were 25 percent above last year and 3 percent ahead of three months earlier.

 

Fourth quarter operating profits of $116 million were improved by $127 million compared to one year ago on $157 million higher revenues, demonstrating the full benefits of aggressive restructuring and lower levels of discounts. Compared to the third quarter, segment profits were up $28 million on a $20 million increase in revenues as segment operating margins improved to 14.7 percent from the third quarter’s 11.5 percent. During the quarter, Test and Measurement achieved an 18 percent Return on Invested Capital (5) (ROIC), up from 14 percent in the third quarter and (0) percent one year ago.

 

Automated Test

(in millions)

 

     Q4:F04

    Q4:F03

   Q3:F04

Orders

   137     260    208

Revenues

   196     260    243

Operating Profit (4)

   (7 )   45    19

 

Fourth quarter Automated Test orders of $137 million were down 47 percent from one year ago to the lowest level since early 2003. All product lines were weaker except parametric test as semiconductor manufacturers slowed production and delayed capital investments. Utilization rates for SOC testers at semiconductor contract manufacturers (SCMs) did improve by about five points to 90 percent during the quarter, suggesting that the period of semiconductor industry digestion and cautious ordering may not be very extended. Revenues of $196 million were 25 percent below last year and down 19 percent sequentially.

 

The segment had an operating loss of $7 million during the quarter compared to profits of $45 million one year ago on $64 million lower revenues. During the quarter, gross margins were depressed by lower volumes and intense competitive pressures. Operating expenses were relatively flat year-to-year, with R&D up and SG&A lower as the company released a new generation of flash memory and SOC test systems. The company entered the flat panel test market during the quarter with the introduction of a new test platform and acquisition of IBM’s flat panel test business.

 

Semiconductor Products

(in millions)

 

     Q4:F04

   Q4:F03

   Q3:F04

Orders

   403    493    470

Revenues

   486    463    539

Operating Profit (4)

   8    40    33

 

Semiconductor Products orders were $403 million during the fourth quarter, down 18 percent from one year ago and off 14 percent sequentially. Orders declined virtually across the board as customers reacted quickly to


excess inventories built up over the past few months. Personal systems orders were down 12 percent from last year and off 16 percent sequentially; networking systems orders dropped 31 percent from last year and were down 9 percent sequentially. Fourth quarter revenues of $486 million were 5 percent above last year and down 10 percent sequentially.

 

Segment profits of $8 million were $32 million below last year despite a $23 million increase in revenues; margins were hurt by severe price pressures in camera modules and fiber optics. Sequentially, profits were down $25 million on a $53 million reduction in revenues. Segment ROIC (5) was 6 percent during the quarter compared to 16 percent one year ago and 15 percent during the third quarter. During the quarter, the company announced plans for the sale of its camera module business to Flextronics.

 

Life Sciences and Chemical Analysis

(in millions)

 

     Q4:F04

   Q4:F03

   Q3:F04

Orders

   366    333    321

Revenues

   352    321    335

Operating Profit (4)

   58    53    46

 

Life Sciences and Chemical Analysis had an outstanding quarter. Orders of $366 million were 10 percent above last year, with Life Sciences orders up 11 percent and Chemical Analysis up 9 percent. Revenues of $352 million were 10 percent above last year and up 5 percent sequentially.

 

Segment profits of $58 million were $5 million above last year on a $31 million increase in revenues; the segment operating margin of 16.5 percent equaled last year’s record level. During the quarter, the segment achieved an ROIC (5) of 25 percent, compared with last year’s ROIC of 30 percent and 23 percent in the third quarter.

 

About Agilent Technologies

 

Agilent Technologies Inc. (NYSE: A) is a global technology leader in communications, electronics, life sciences and chemical analysis. The company’s 28,000 employees serve customers in more than 110 countries. Agilent had net revenue of $7.2 billion in fiscal year 2004. Information about Agilent is available on the Web at www.agilent.com.

 

Agilent management will host a live webcast of its quarterly conference call with the investment community in listen-only mode today at 1:30 p.m. (PT). Listeners may log on at www.investor.agilent.com and select “Fourth Quarter FY04 Financial Results Conference Call” under “Events & Presentations.” The webcast will remain on the company site for 90 days.

 

A telephone replay of the conference call will be available from 4:30 p.m. (PT) today through Nov. 18 by dialing + 1 719 457 0820 and entering pass code 835568.

 

Forward-Looking Statements

 

This news release contains forward-looking statements (including, without limitation, information regarding the markets we serve and the conditions in those markets, growth rates in our businesses, revenues, operating margins, costs and earnings) that involve risks and uncertainties that could cause results of Agilent to differ materially from management’s current expectations.

 

In addition, other risks that Agilent faces in running its operations include the ability to execute successfully through business cycles while it continues to implement workforce and other cost reductions; the ability to meet and achieve the benefits of its cost-reduction goals and otherwise successfully adapt its cost structures to continuing changes in business conditions; ongoing competitive, pricing and gross margin pressures; the risk that our cost-cutting initiatives will impair our ability to develop products and remain competitive and to operate effectively; the impact of geopolitical uncertainties on our markets and our ability to conduct business; the ability to improve asset performance to adapt to changes in demand; the ability to successfully introduce new products at the right time, price and mix, and other risks detailed in Agilent’s filings with the Securities and Exchange Commission, including our Quarterly Report on Form 10-Q for the quarter ended July 31, 2004.

 

# # #



(1) Before net restructuring and amortization charges in all periods.

 

(2) Free cash flow is defined as Net Cash provided by operating activities less Investments in property, plant and equipment.

 

(3) Agilent’s expected range of EPS for Q105 excludes restructuring, which cannot be estimated, and amortization of intangibles, which is expected to be approximately $1 million per quarter. The annual non-GAAP tax rate is assumed to be 24 percent. Beginning in Q304, Agilent is treating its senior convertible debentures as “if converted.” As a result, approximately 36 million shares were added to the denominator of diluted EPS, and $6.2 million of associated after-tax quarterly interest expense was added back to the numerator.

 

(4) Before restructuring charges in all periods.

 

(5 ) Refer to financial results tables for ROIC.


AGILENT TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

(In millions, except per share amounts)

(Unaudited)

 

    

Three Months Ended

October 31,


  

Percent

Inc/(Dec)


 
     2004

   2003

  

Orders

   $ 1,599    $ 1,731    (8 )%
    

  

      

Net revenue

   $ 1,822    $ 1,675    9 %

Costs and expenses:

                    

Cost of products and services

     1,042      961    8 %

Research and development

     232      221    5 %

Selling, general and administrative

     459      437    5 %
    

  

      

Total costs and expenses

     1,733      1,619    7 %
    

  

      

Income from operations

     89      56    59 %

Other income (expense), net

     7      21    (67 )%
    

  

      

Income from operations before taxes

     96      77    25 %

Provision for taxes

     22      64    (66 )%
    

  

      

Net income

   $ 74    $ 13    469 %
    

  

      
Net income per share:                     

Basic

   $ 0.15    $ 0.03       

Diluted

   $ 0.15    $ 0.03       

Weighted average shares used in computing net income per share:

             

Basic

     486      476       

Diluted

     490      481       

 

Historical amounts were reclassified to conform with current period presentation.


AGILENT TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

(In millions, except per share amounts)

(Unaudited)

 

     Twelve Months Ended
October 31,


   

Percent

Inc/(Dec)


 
     2004

   2003

   

Orders

   $ 6,997    $ 6,084     15 %
    

  


     

Net revenue

   $ 7,181    $ 6,056     19 %

Costs and expenses:

                     

Cost of products and services

     4,058      3,750     8 %

Research and development

     933      1,051     (11 )%

Selling, general and administrative

     1,804      1,980     (9 )%
    

  


     

Total costs and expenses

     6,795      6,781     —    
    

  


     

Income (loss) from operations

     386      (725 )   153 %

Other income (expense), net

     54      35     54 %
    

  


     

Income (loss) before taxes

     440      (690 )   164 %

Provision for taxes

     91      1,100     (92 )%
    

  


     

Income (loss) before cumulative effect of accounting change

     349      (1,790 )   119 %

Cumulative effect of adopting SFAS No. 142

     —        (268 )      
    

  


     

Net income (loss)

   $ 349    $ (2,058 )   117 %
    

  


     
Net income (loss) per share:                      
Basic                      

Income (loss) before cumulative effect of accounting change

   $ 0.72    $ (3.78 )      

Cumulative effect of adopting SFAS No. 142

     —        (0.57 )      
    

  


     

Net income (loss)

   $ 0.72    $ (4.35 )      
    

  


     
Diluted                      

Income (loss) before cumulative effect of accounting change

   $ 0.71    $ (3.78 )      

Cumulative effect of adopting SFAS No. 142

     —        (0.57 )      
    

  


     

Net income (loss)

   $ 0.71    $ (4.35 )      
    

  


     

Weighted average shares used in computing net income (loss) per share:

                     

Basic

     483      473        

Diluted

     490      473        

Historical amounts were reclassified to conform with current period presentation.

                     


AGILENT TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

Excluding Restructuring, Amortization of Intangibles

and Non-Operational Items

(Unaudited)

 

    

Three Months Ended
October 31,


   

Percent

Inc/(Dec)


 
(In millions, except per share amounts)    2004

    2003

   

Orders

   $ 1,599     $ 1,731     (8 )%
    


 


     

Net revenue

   $ 1,822     $ 1,675     9 %

Costs and expenses:

                      

Cost of products and services

     1,006       938     7 %

Research and development

     228       218     5 %

Selling, general and administrative

     415       397     5 %
    


 


 

Total costs and expenses

     1,649       1,553     6 %
    


 


 

Income from operations

     173       122     42 %

Other income (expense), net

     20       21     (5 )%
    


 


     

Income before taxes

     193       143     35 %

Provision for taxes

     40       72     (44 )%
    


 


     

Non-GAAP net income

   $ 153     $ 71     115 %
    


 


     
Non-GAAP net income per share:                       

Basic

   $ 0.31     $ 0.15        

Diluted

   $ 0.30     $ 0.15        

Weighted average shares used in computing non-GAAP net income per share:

                      

Basic

     486       476        

Diluted

     526       481        
The above non-GAAP condensed consolidated statement of operations has been adjusted to exclude the following items and reconcile to GAAP net income:                       

Net income per GAAP

   $ 74     $ 13        

Non-GAAP adjustments:

                      

Other intangibles

     1       9        

Restructuring and asset impairment

     54       58        

Gain on sale of assets

     —         (2 )      

Investment Impairments

     7       —          

Camera module charge

     18       —          

Other

     17       1        

Adjustment for income taxes

     (18 )     (8 )      
    


 


     

Non-GAAP net income

   $ 153     $ 71        
    


 


     

 

We provide non-GAAP financial information in order to provide meaningful supplemental information regarding our operational performance and to enhance our investors’ overall understanding of our core current financial performance and our prospects for the future. We believe that our investors benefit from seeing our results “through the eyes” of management in addition to the GAAP presentation. Management measures segment and enterprise performance using measures such as are disclosed in this release. This information facilitates management’s internal comparisons to the company’s historical operating results and comparisons to competitors operating results.

 

Non-GAAP information allows for greater transparency to supplemental information used by management in its financial and operational decision making. Historically, we have reported similar non-GAAP information to our investors and believe that the inclusion of comparative numbers provides consistency in our financial reporting.

 

This information is not in accordance with, or an alternative for, generally accepted accounting principles in the United States. It excludes items, such as restructuring and amortization, that may have a material effect on the company’s net income (loss) and net income (loss) per share calculated in accordance with GAAP. Management monitors these items to ensure that expenses are in line with expectations and that our GAAP results are correctly stated but does not use them to measure the ongoing operating performance of the company. The non-GAAP information we provide may be different from the non-GAAP information provided by other companies.

 

Historical amounts were reclassified to conform with current period presentation.

 


AGILENT TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

Excluding Restructuring, Amortization of Intangibles

and Non-Operational Items

(Unaudited)

 

     Twelve Months
Ended October 31,


   

Percent

Inc/(Dec)


 
(In millions, except per share amounts)    2004

    2003

   

Orders

   $ 6,997     $ 6,084     15 %
    


 


     

Net revenue

   $ 7,181     $ 6,056     19 %

Costs and expenses:

                      

Cost of products and services

     3,955       3,587     10 %

Research and development

     914       984     (7 )%

Selling, general and administrative

     1,670       1,774     (6 )%
    


 


     

Total costs and expenses

     6,539       6,345     3 %
    


 


     

Income (loss) from operations

     642       (289 )   322 %

Other income (expense), net

     73       47     55 %
    


 


     

Income (loss) before taxes

     715       (242 )   395 %

Provision (benefit) for taxes

     186       (121 )   254 %
    


 


     

Non-GAAP income (loss)

   $ 529     $ (121 )   537 %
    


 


     

Non-GAAP net income (loss) per share:

                      

Basic

   $ 1.10     $ (0.26 )      

Diluted

   $ 1.05     $ (0.26 )      

Weighted average shares used in computing non-GAAP net income (loss) per share:

                      

Basic

     483       473        

Diluted

     526       473        

The above non-GAAP condensed consolidated statement of operations has been adjusted to exclude the following items and reconcile to GAAP net income (loss:)

   

Net income (loss) per GAAP

   $ 349     $ (2,058 )      

Non-GAAP adjustments:

                      

Other intangibles

     22       55        

Restructuring and asset impairment

     169       387        

Gain on sale of assets

     (1 )     (5 )      

SFAS No. 142 adoption

     —         268        

Retirement plans curtailment loss

     —         5        

Investment Impairment

     7       —          

Camera module charge

     18       —          

Contract termination fees

     14       —          

Other

     46       6        

Adjustment for income taxes

     (95 )     1,221        
    


 


     

Non-GAAP net income (loss)

   $ 529     $ (121 )      
    


 


     

 

We provide non-GAAP financial information in order to provide meaningful supplemental information regarding our operational performance and to enhance our investors’ overall understanding of our core current financial performance and our prospects for the future. We believe that our investors benefit from seeing our results “through the eyes” of management in addition to the GAAP presentation. Management measures segment and enterprise performance using measures such as are disclosed in this release. This information facilitates management’s internal comparisons to the company’s historical operating results and comparisons to competitors operating results.

 

Non-GAAP information allows for greater transparency to supplemental information used by management in its financial and operational decision making. Historically, we have reported similar non-GAAP information to our investors and believe that the inclusion of comparative numbers provides consistency in our financial reporting.

 

This information is not in accordance with, or an alternative for, generally accepted accounting principles in the United States. It excludes items, such as restructuring and amortization, that may have a material effect on the company’s net income (loss) and net income (loss) per share calculated in accordance with GAAP. Management monitors these items to ensure that expenses are in line with expectations and that our GAAP results are correctly stated but does not use them to measure the ongoing operating performance of the company. The non-GAAP information we provide may be different from the non-GAAP information provided by other companies.

 

Historical amounts were reclassified to conform with current period presentation.


AGILENT TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEET

(In millions, except par value and share amounts)

(Unaudited)

 

     October 31,
2004


    October 31,
2003


 

ASSETS

                

Current assets:

                

Cash and cash equivalents

   $ 2,315     $ 1,607  

Accounts receivable, net

     1,044       1,086  

Inventory

     1,026       995  

Other current assets

     192       201  
    


 


Total current assets

     4,577       3,889  

Property, plant and equipment, net

     1,258       1,447  

Goodwill and other intangible assets, net

     443       402  

Other assets

     778       559  
    


 


Total assets

   $ 7,056     $ 6,297  
    


 


LIABILITIES AND STOCKHOLDERS’ EQUITY

                

Current liabilities:

                

Accounts payable

   $ 441     $ 441  

Employee compensation and benefits

     549       566  

Deferred revenue

     284       262  

Income and other taxes payable

     340       326  

Other accrued liabilities

     261       311  
    


 


Total current liabilities

     1,875       1,906  
    


 


Senior convertible debentures

     1,150       1,150  

Other liabilities

     466       417  
    


 


Total liabilities

     3,491       3,473  
    


 


Commitments and contingencies

     —         —    

Stockholders’ equity:

                

Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding

     —         —    

Common stock; $0.01 par value; 2 billion shares authorized; 487 million shares at October 31, 2004 and 476 million shares at October 31, 2003 issued and outstanding

     5       5  

Additional paid-in capital

     5,193       4,984  

Accumulated deficit

     (1,810 )     (2,159 )

Accumulated comprehensive income (loss)

     177       (6 )
    


 


Total stockholders’ equity

     3,565       2,824  
    


 


Total liabilities and stockholders’ equity

   $ 7,056     $ 6,297  
    


 



AGILENT TECHNOLOGIES, INC.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS

(In millions)

(Unaudited)

 

    

Twelve months
ended

October 31,
2004


    Three months
ended
October 31,
2004


 

Cash flows from operating activities:

                

Net income

   $ 349     $ 74  

Adjustments to reconcile net income to net cash provided by operating activities:

                

Depreciation

     266       65  

Amortization

     26       1  

Deferred taxes

     31       17  

Asset impairment charges

     40       15  

Net gain (loss) on sale of assets

     1       (4 )

Changes in assets and liabilities:

                

Accounts receivable

     116       166  

Inventory

     (31 )     39  

Accounts payable

     76       105  

Employee compensation and benefits

     29       54  

Income taxes and other taxes payable

     (82 )     (31 )

Other current assets and liabilities

     (9 )     38  

Other long-term assets and liabilities

     (136 )     (117 )
    


 


Net cash provided by operating activities (1)

     676       422  

Cash flows from investing activities:

                

Investments in property, plant and equipment

     (118 )     (28 )

Dispositions of property, plant and equipment

     36       —    

Acquisitions, net of cash acquired

     (18 )     (18 )

Purchased intangibles and investments

     (13 )     (6 )
    


 


Net cash used in investing activities

     (113 )     (52 )

Cash flows from financing activities:

                

Issuance of common stock under employee stock plans

     144       8  

Net borrowings of notes payable and short-term borrowings

     1       —    
    


 


Net cash provided by financing activities

     145       8  

Change in cash and cash equivalents

     708       378  

Cash and cash equivalents at beginning of period

     1,607       1,937  
    


 


Cash and cash equivalents at end of period

   $ 2,315     $ 2,315  
    


 



(1)       Cash payments included in operating activities:

                

Restructuring

     138       33  

Income tax payments

     149       67  

Pension trust fund contributions

     122       8  


AGILENT TECHNOLOGIES, INC

RECONCILIATION FROM GAAP TO NON-GAAP

NET INCOME

THREE MONTHS ENDED OCTOBER 31, 2004

(Unaudited)

 

          Non-GAAP Adjustments

       

(In millions, except
per share amounts)

 

   GAAP

   Other
Intangibles


    Restructuring and
Asset Impairment


    Camera
Module Charge


    Investment
Impairments


   Other

    Adjustment for
Income Taxes


    Non-GAAP

 

Orders

   $ 1,599    $ —       $ —       $ —       $ —      $ —       $ —       $ 1,599  
    

  


 


 


 

  


 


 


Net revenue

   $ 1,822    $ —       $ —       $ —       $ —      $ —       $ —         1,822  

Costs and expenses:

                                                              

Cost of products and services

     1,042      (1 )     (15 )     (18 )     —        (2 )     —         1,006  

Research and development

     232      —         (4 )     —         —        —         —         228  

Selling, general and administrative

     459      —         (35 )     —         —        (9 )     —         415  
    

  


 


 


 

  


 


 


Total costs and expenses

     1,733      (1 )     (54 )     (18 )     —        (11 )     —         1,649  
    

  


 


 


 

  


 


 


Income from operations

     89      1       54       18       —        11       —         173  

Other income (expense), net

     7      —         —         —         7      6       —         20  
    

  


 


 


 

  


 


 


Income from operations before taxes

     96      1       54       18       7      17       —         193  

Provision for taxes

     22      —         —         —         —        —         18       40  
    

  


 


 


 

  


 


 


Net income

   $ 74    $ 1     $ 54     $ 18     $ 7    $ 17     $ (18 )   $ 153  
    

  


 


 


 

  


 


 


Net income per share - Basic and Diluted:

                                                              

Basic

   $ 0.15    $ 0.00     $ 0.11     $ 0.04     $ 0.01    $ 0.04     $ (0.04 )   $ 0.31  

Diluted

   $ 0.15    $ 0.00     $ 0.11     $ 0.04     $ 0.01    $ 0.03     $ (0.04 )   $ 0.30 (1)

Weighted average shares used in computing net income per share:

                                                              

Basic

     486      486       486       486       486      486       486       486  

Diluted

     490      490       490       490       490      490       490       526 (1)

(1) In order to calculate non-GAAP diluted net income per share, we added 36 million shares and approximately $6 million of after-tax interest expense to non-GAAP net income to treat our senior convertible debentures as if they were converted. The impact of this was ($.01) to our diluted earnings per share.

 

We provide non-GAAP financial information in order to provide meaningful supplemental information regarding our operational performance and to enhance our investors’ overall understanding of our core current financial performance and our prospects for the future. We believe that our investors benefit from seeing our results “through the eyes” of management in addition to the GAAP presentation. Management measures segment and enterprise performance using measures such as those that are disclosed in this release. This information facilitates management’s internal comparisons to the company’s historical operating results and comparisons to competitors’ operating results.

 

Non-GAAP information allows for greater transparency to supplemental information used by management in its financial and operational decision making. Historically, we have reported similar non-GAAP information to our investors and believe that the inclusion of comparative numbers provides consistency in our financial reporting.

 

This information is not in accordance with, or an alternative for, generally accepted accounting principles in the United States. It excludes items, such as restructuring and amortization, that may have a material effect on the company’s net income (loss) and net income (loss) per share calculated in accordance with GAAP. Management monitors these items to ensure that expenses are in line with expectations and that our GAAP results are correctly stated but does not use them to measure the ongoing operating performance of the company. The non-GAAP information we provide may be different from the non-GAAP information provided by other companies.


AGILENT TECHNOLOGIES, INC

RECONCILIATION FROM GAAP TO NON-GAAP

NET INCOME

TWELVE MONTHS ENDED OCTOBER 31, 2004

(Unaudited)

 

        Non-GAAP Adjustments

       

(In millions, except
per share amounts)

 

  GAAP

  Other
Intangibles


    Restructuring and
Asset Impairment


    Contract
Termination Fees


    Gain On
Sale of Assets


    Camera
Module Charge


    Investment
Impairments


  Other

    Adjustment for
Income Taxes


    Non-GAAP

 

Orders

  $ 6,997   $ —       $ —       $ —       $ —       $ —       $ —     $ —       $ —       $ 6,997  
   

 


 


 


 


 


 

 


 


 


Net revenue

  $ 7,181   $ —       $ —       $ —       $ —       $ —       $ —     $ —       $ —       $ 7,181  

Costs and expenses:

                                                                           

Cost of products and services

    4,058     (19 )     (54 )     (4 )     —         (18 )     —       (8 )     —         3,955  

Research and development

    933     —         (16 )     (3 )     —         —         —       —         —         914  

Selling, general and administrative

    1,804     (3 )     (91 )     (7 )     1       —         —       (34 )     —         1,670  
   

 


 


 


 


 


 

 


 


 


Total costs and expenses

    6,795     (22 )     (161 )     (14 )     1       (18 )     —       (42 )     —         6,539  
   

 


 


 


 


 


 

 


 


 


Income from operations

    386     22       161       14       (1 )     18       —       42       —         642  

Other income (expense), net

    54     —         8       —         —         —         7     4       —         73  
   

 


 


 


 


 


 

 


 


 


Income from operations before taxes

    440     22       169       14       (1 )     18       7     46       —         715  

Provision for taxes

    91     —         —         —         —         —         —       —         95       186  
   

 


 


 


 


 


 

 


 


 


Net income

  $ 349   $ 22     $ 169     $ 14     $ (1 )   $ 18     $ 7   $ 46     $ (95 )   $ 529  
   

 


 


 


 


 


 

 


 


 


Net income per share - Basic and Diluted:

                                                                           

Basic

  $ 0.72   $ 0.05     $ 0.35     $ 0.03     $ (0.00 )   $ 0.04     $ 0.01   $ 0.10     $ (0.20 )   $ 1.10  

Diluted

  $ 0.71   $ 0.04     $ 0.34     $ 0.03     $ (0.00 )   $ 0.04     $ 0.01   $ 0.09     $ (0.19 )   $ 1.05 (1)

Weighted average shares used in computing net income per share:

                                                                           

Basic

    483     483       483       483       483       483       483     483       483       483  

Diluted

    490     490       490       490       490       490       490     490       490       526 (1)

(1) In order to calculate non-GAAP diluted net income per share, we added 36 million shares and approximately $26 million of after-tax interest expense to non-GAAP net income to treat our senior convertible debentures as if they were converted. The impact of this was ($.03) to our diluted earnings per share.

 

We provide non-GAAP financial information in order to provide meaningful supplemental information regarding our operational performance and to enhance our investors’ overall understanding of our core current financial performance and our prospects for the future. We believe that our investors benefit from seeing our results “through the eyes” of management in addition to the GAAP presentation. Management measures segment and enterprise performance using measures such as those that are disclosed in this release. This information facilitates management’s internal comparisons to the company’s historical operating results and comparisons to competitors’ operating results.

 

Non-GAAP information allows for greater transparency to supplemental information used by management in its financial and operational decision making. Historically, we have reported similar non-GAAP information to our investors and believe that the inclusion of comparative numbers provides consistency in our financial reporting.

 

This information is not in accordance with, or an alternative for, generally accepted accounting principles in the United States. It excludes items, such as restructuring and amortization, that may have a material effect on the company’s net income (loss) and net income (loss) per share calculated in accordance with GAAP. Management monitors these items to ensure that expenses are in line with expectations and that our GAAP results are correctly stated but does not use them to measure the ongoing operating performance of the company. The non-GAAP information we provide may be different from the non-GAAP information provided by other companies.


AGILENT TECHNOLOGIES, INC

RECONCILIATION FROM GAAP TO NON-GAAP

NET INCOME

THREE MONTHS ENDED OCTOBER 31, 2003

(Unaudited)

 

          Non-GAAP Adjustments

     
(In millions, except per share amounts)    GAAP

   Other
Intangibles


    Restructuring and
Asset Impairment


    Gain on Sale
of Assets


    Other

    Adjustment
for Income Taxes


    Non-GAAP

Orders

   $ 1,731    $ —       $ —       $ —       $ —       $ —       $ 1,731
    

  


 


 


 


 


 

Net revenue

   $ 1,675    $ —       $ —       $ —       $ —       $ —       $ 1,675

Costs and expenses:

                                                     

Cost of products and services

     961      (8 )     (15 )     —         —         —         938

Research and development

     221      —         (3 )     —         —         —         218

Selling, general and administrative

     437      (1 )     (40 )     2       (1 )     —         397
    

  


 


 


 


 


 

Total costs and expenses

     1,619      (9 )     (58 )     2       (1 )     —         1,553
    

  


 


 


 


 


 

Income from operations

     56      9       58       (2 )     1       —         122

Other income (expense), net

     21      —         —         —         —         —         21
    

  


 


 


 


 


 

Income before taxes

     77      9       58       (2 )     1       —         143

Provision for taxes

     64      —         —         —         —         8       72
    

  


 


 


 


 


 

Net income

   $ 13    $ 9     $ 58     $ (2 )   $ 1     $ (8 )   $ 71
    

  


 


 


 


 


 

Net income per share - Basic and Diluted:

                                                     

Basic

   $ 0.03    $ 0.02     $ 0.12     $ —       $ 0.00     $ (0.02 )   $ 0.15
    

  


 


 


 


 


 

Diluted

   $ 0.03    $ 0.02     $ 0.12     $ —       $ 0.00     $ (0.02 )   $ 0.15
    

  


 


 


 


 


 

Weighted average shares used in computing net income per share:

                                                     

Basic

     476      476       476       476       476       476       476

Diluted

     481      481       481       481       481       481       481

 

We provide non-GAAP financial information in order to provide meaningful supplemental information regarding our operational performance and to enhance our investors’ overall understanding of our core current financial performance and our prospects for the future. We believe that our investors benefit from seeing our results “through the eyes” of management in addition to the GAAP presentation. Management measures segment and enterprise performance using measures such as those that are disclosed in this release. This information facilitates management’s internal comparisons to the company’s historical operating results and comparisons to competitors’ operating results.

 

Non-GAAP information allows for greater transparency to supplemental information used by management in its financial and operational decision making. Historically, we have reported similar non-GAAP information to our investors and believe that the inclusion of comparative numbers provides consistency in our financial reporting.

 

This information is not in accordance with, or an alternative for, generally accepted accounting principles in the United States. It excludes items, such as restructuring and amortization, that may have a material effect on the company’s net income (loss) and net income (loss) per share calculated in accordance with GAAP. Management monitors these items to ensure that expenses are in line with expectations and that our GAAP results are correctly stated but does not use them to measure the ongoing operating performance of the company. The non-GAAP information we provide may be different from the non-GAAP information provided by other companies.

 

Historical amounts were reclassified to conform with current period presentation.


AGILENT TECHNOLOGIES, INC

RECONCILIATION FROM GAAP TO NON-GAAP

NET LOSS

TWELVE MONTHS ENDED OCTOBER 31, 2003

(Unaudited)

 

          Non-GAAP Adjustments

       
(In millions, except per share amounts)   GAAP

    Other
Intangibles


    Restructuring and
Asset Impairment


    Gain on Sale
of Assets


    SFAS No.
142


  Retirement Plans
Curtailment Loss


    Other

    Adjustment for
Income Taxes


    Non-GAAP

 
                                                                       

Orders

  $ 6,084     $ —       $ —       $ —       $ —     $ —       $ —       $ —       $ 6,084  
   


 


 


 


 

 


 


 


 


Net revenue

  $ 6,056     $ —       $ —       $ —       $ —     $ —       $ —       $ —       $ 6,056  

Costs and expenses:

                                                                     

Cost of products and services

    3,750       (46 )     (111 )     —         —       (1 )     (5 )     —         3,587  

Research and development

    1,051       —         (66 )     —         —       (1 )     —         —         984  

Selling, general and administrative

    1,980       (9 )     (195 )     2       —       (3 )     (1 )     —         1,774  
   


 


 


 


 

 


 


 


 


Total costs and expenses

    6,781       (55 )     (372 )     2       —       (5 )     (6 )     —         6,345  
   


 


 


 


 

 


 


 


 


Loss from operations

    (725 )     55       372       (2 )     —       5       6       —         (289 )

Other income (expense), net

    35       —         15       (3 )     —       —         —         —         47  
   


 


 


 


 

 


 


 


 


Loss from operations before taxes

    (690 )     55       387       (5 )     —       5       6       —         (242 )

Provision for taxes

    1,100       —         —         —         —       —         —         (1,221 )     (121 )
   


 


 


 


 

 


 


 


 


Loss before cumulative effect of accounting change

    (1,790 )     55       387       (5 )     —       5       6       1,221       (121 )

Cumulative effect of adopting SFAS No. 142

    (268 )     —         —         —         268     —         —         —         —    
   


 


 


 


 

 


 


 


 


Net loss

  $ (2,058 )   $ 55     $ 387     $ (5 )   $ 268   $ 5     $ 6     $ 1,221     $ (121 )
   


 


 


 


 

 


 


 


 


Net loss per share - Basic and Diluted:

                                                                     

Loss before cumulative effect of accounting change

  $ (3.78 )   $ 0.11     $ 0.82     $ (0.01 )   $ —     $ 0.01     $ 0.01     $ 2.58     $ (0.26 )

Cumulative effect of adopting SFAS No. 142

    (0.57 )     —         —         —         0.57     —         —         —         —    
   


 


 


 


 

 


 


 


 


Net loss

  $ (4.35 )   $ 0.11     $ 0.82     $ (0.01 )   $ 0.57   $ 0.01     $ 0.01     $ 2.58     $ (0.26 )
   


 


 


 


 

 


 


 


 


Weighted average shares used in computing net loss per share:

                                                                     

Basic and diluted

    473       473       473       473       473     473       473       473       473  

 

We provide non-GAAP financial information in order to provide meaningful supplemental information regarding our operational performance and to enhance our investors’ overall understanding of our core current financial performance and our prospects for the future. We believe that our investors benefit from seeing our results “through the eyes” of management in addition to the GAAP presentation. Management measures segment and enterprise performance using measures such as those that are disclosed in this release. This information facilitates management’s internal comparisons to the company’s historical operating results and comparisons to competitors’ operating results.

 

Non-GAAP information allows for greater transparency to supplemental information used by management in its financial and operational decision making. Historically, we have reported similar non-GAAP information to our investors and believe that the inclusion of comparative numbers provides consistency in our financial reporting.

 

This information is not in accordance with, or an alternative for, generally accepted accounting principles in the United States. It excludes items, such as restructuring and amortization, that may have a material effect on the company’s net income (loss) and net income (loss) per share calculated in accordance with GAAP. Management monitors these items to ensure that expenses are in line with expectations and that our GAAP results are correctly stated but does not use them to measure the ongoing operating performance of the company. The non-GAAP information we provide may be different from the non-GAAP information provided by other companies.

 

Historical amounts were reclassified to conform with current period presentation.


AGILENT TECHNOLOGIES, INC.

TEST AND MEASUREMENT INFORMATION

(In millions, except percent changes)

(Unaudited)

 

    

Three months

ended

October 31,

2004


  

Three months
ended

October 31,
2003


   

Yr vs. Yr

% change


   

Three months
ended

July 31,

2004


   Sequential
% change


 

Orders

   $ 693    $ 645     7 %   $ 776    (11 )%

Net Revenue

   $ 788    $ 631     25 %   $ 768    3 %

Income (loss) from operations

   $ 116    $ (11 )   1155 %   $ 88    32 %

 

    

Twelve months

ended

October 31,

2004


  

Twelve months
ended

October 31,
2003


   

Yr vs. Yr

% change


 

Orders

   $ 2,856    $ 2,413     18 %

Net Revenue

   $ 2,903    $ 2,529     15 %

Income (loss) from operations

   $ 219    $ (315 )   170 %

 

Q4 FY04 vs Q3 FY04 BY MARKET SEGMENT

 

     Orders

    Net Revenue

 
    

Q4 FY04

$ Amount


   Sequential
% change


    % of
Segment


   

Q4 FY04

$
Amount


   Sequential
% change


    % of
Segment


 

Communications test

   $ 460    (16 )%   66 %   $ 547    2 %   69 %

General purpose test

     233    2 %   34 %     241    5 %   31 %
    

        

 

        

     $ 693    (11 )%   100 %   $ 788    3 %   100 %
    

        

 

        

 

Q4 FY04 vs Q4 FY03 BY MARKET SEGMENT

 

     Orders

    Net Revenue

 
     Q4 FY04
$ Amount


   Yr vs. Yr
% change


    Q4 FY04
$ Amount


   Yr vs. Yr
% change


 

Communications test

   $ 460    3 %   $ 547    28 %

General purpose test

     233    17 %     241    18 %
    

        

      
     $ 693    7 %   $ 788    25 %
    

        

      

 

Income (loss) from operations reflect the results of our reportable segments under Agilent’s management reporting system which are not necessarily in conformity with accounting principles generally accepted in the United States (GAAP). Income (loss) from operations of our reporting segments excludes restructuring, amortization of intangibles, non-operational charges and unallocated infrastructure charges.

 

In general, recorded orders represent firm purchase commitments from our customers with established terms and conditions for products and services that will be delivered within six months.


AGILENT TECHNOLOGIES, INC.

AUTOMATED TEST INFORMATION

(In millions, except percent changes)

(Unaudited)

 

     Three months
ended
October 31,
2004


    Three months
ended
October 31,
2003


   Yr vs. Yr
% change


   

Three months
ended

July 31,

2004


   Sequential
% change


 

Orders

   $ 137     $ 260    (47 )%   $ 208    (34 )%

Net Revenue

   $ 196     $ 260    (25 )%   $ 243    (19 )%

Income from operations

   $ (7 )   $ 45    (116 )%   $ 19    (137 )%

 

     Twelve months
ended
October 31,
2004


  

Twelve months
ended

October 31,
2003


    Yr vs. Yr
% change


 

Orders

   $ 831    $ 845     (2 )%

Net Revenue

   $ 924    $ 755     22 %

Income (loss) from operations

   $ 66    $ (34 )   294 %

 

Q4 FY04 vs Q3 FY04 BY MARKET SEGMENT

 

     Orders

    Net Revenue

 
     Q4 FY04
$ Amount


   Sequential
% change


    % of
Segment


    Q4 FY04
$ Amount


   Sequential
% change


    % of
Segment


 

Semiconductor test

   $ 107    (33 )%   78 %   $ 157    (20 )%   80 %

Manufacturing test

     30    (39 )%   22 %     39    (15 )%   20 %
    

        

 

        

     $ 137    (34 )%   100 %   $ 196    (19 )%   100 %
    

        

 

        

 

Q4 FY04 vs Q4 FY03 BY MARKET SEGMENT

 

     Orders

    Net Revenue

 
     Q4 FY04
$ Amount


   Yr vs.Yr
% change


    Q4 FY04
$ Amount


  

Yr vs.Yr

% change


 

Semiconductor test

   $ 107    (51 )%   $ 157    (29 )%

Manufacturing test

     30    (27 )%     39      %
    

        

      
     $ 137    (47 )%   $ 196    (25 )%
    

        

      

 

Income (loss) from operations reflect the results of our reportable segments under Agilent’s management reporting system which are not necessarily in conformity with accounting principles generally accepted in the United States (GAAP). Income (loss) from operations of our reporting segments excludes restructuring, amortization of intangibles, non-operational charges and unallocated infrastructure charges.

 

In general, recorded orders represent firm purchase commitments from our customers with established terms and conditions for products and services that will be delivered within six months.


AGILENT TECHNOLOGIES, INC.

SEMICONDUCTOR PRODUCTS INFORMATION

(In millions, except percent changes)

(Unaudited)

 

     Three months
ended
October 31,
2004


   Three months
ended
October 31,
2003


   Yr vs.Yr
% change


   

Three months
ended

July 31,

2004


   Sequential
% change


 

Orders

   $ 403    $ 493    (18 )%   $ 470    (14 )%

Net Revenue

   $ 486    $ 463    5 %   $ 539    (10 )%

Income from operations

   $ 8    $ 40    (80 )%   $ 33    (76 )%

 

    

Twelve months
ended

October 31,
2004


  

Twelve months
ended

October 31,
2003


    Yr vs. Yr
% change


 

Orders

   $ 1,978    $ 1,652     20 %

Net Revenue

   $ 2,021    $ 1,586     27 %

Income (loss) from operations

   $ 166    $ (59 )   381 %

 

Q4 FY04 vs Q3 FY04 BY MARKET SEGMENT

 

     Orders

    Net Revenue

 
    

Q4 FY04

$ Amount


   Sequential
% change


    % of
Segment


    Q4 FY04
$ Amount


   Sequential
% change


    % of
Segment


 

Networking

   $ 116    (9 )%   29 %   $ 122    (12 )%   25 %

Personal systems

     287    (16 )%   71 %     364    (9 )%   75 %
    

        

 

        

     $ 403    (14 )%   100 %   $ 486    (10 )%   100 %
    

        

 

        

 

Q4 FY04 vs Q4 FY03 BY MARKET SEGMENT

 

     Orders

    Net Revenue

 
     Q4 FY04
$ Amount


   Yr vs. Yr
% change


    Q4 FY04
$ Amount


   Yr vs. Yr
% change


 

Networking

   $ 116    (31 )%   $ 122    (21 )%

Personal systems

     287    (12 )%     364    18 %
    

        

      
     $ 403    (18 )%   $ 486    5 %
    

        

      

 

Income (loss) from operations reflect the results of our reportable segments under Agilent’s management reporting system which are not necessarily in conformity with accounting principles generally accepted in the United States (GAAP). Income (loss) from operations of our reporting segments excludes restructuring, amortization of intangibles, non-operational charges and unallocated infrastructure charges.

 

In general, recorded orders represent firm purchase commitments from our customers with established terms and conditions for products that will be delivered within six months.


AGILENT TECHNOLOGIES, INC.

LIFE SCIENCES AND CHEMICAL ANALYSIS INFORMATION

(In millions, except percent changes)

(Unaudited)

 

     Three months
ended
October 31,
2004


   Three months
ended
October 31,
2003


   Yr vs. Yr
% change


   

Three months
ended

July 31,

2004


   Sequential
% change


 

Orders

   $ 366    $ 333    10 %   $ 321    14 %

Net Revenue

   $ 352    $ 321    10 %   $ 335    5 %

Income from operations

   $ 58    $ 53    9 %   $ 46    26 %

 

    

Twelve months
ended

October 31,
2004


  

Twelve months
ended

October 31,
2003


   Yr vs. Yr
% change


 

Orders

   $ 1,332    $ 1,174    13 %

Net Revenue

   $ 1,333    $ 1,186    12 %

Income from operations

   $ 192    $ 148    30 %

 

Income (loss) from operations reflect the results of our reportable segments under Agilent’s management reporting system which are not necessarily in conformity with accounting principles generally accepted in the United States (GAAP). Income from operations of our reporting segments excludes restructuring, amortization of intangibles, non-operational charges and unallocated infrastructure charges.

 

In general, recorded orders represent firm purchase commitments from our customers with established terms and conditions for products and services that will be delivered within six months.


AGILENT TECHNOLOGIES, INC.

Segment Income (Loss) from Operations

Reconciliation of Reporting Segments to Agilent Non-GAAP Income (Loss)

(In millions)

(Unaudited)

 

     Three months ended
October 31,


   

Three months ended

July 31,


 
     2004

    2003

    2004

 

Test and Measurement

   $ 116     $ (11 )   $ 88  

Semiconductor Products

     8       40       33  

Automated Test

     (7 )     45       19  

Life Sciences and Chemical Analysis

     58       53       46  

Unallocated infrastructure charges

     (2 )     (5 )     (3 )
    


 


 


Non-GAAP income from operations - Agilent

   $ 173     $ 122     $ 183  
    


 


 


 

Income (loss) from operations reflect the results of our reportable segments under Agilent’s management reporting system which are not necessarily in conformity with accounting principles generally accepted in the United States (GAAP). Income (loss) from operations of our reporting segments excludes restructuring, amortization of intangibles, non-operational charges and unallocated infrastructure charges.


AGILENT TECHNOLOGIES, INC.

ORDERS AND NET REVENUE FROM OPERATIONS

BY GEOGRAPHY

(In millions, except percent changes)

(Unaudited)

 

     Three Months Ended
October 31,


   Percent
Inc/(Dec)


 
     2004

   2003

  

ORDERS

                    

Americas

   $ 586    $ 665    (12 )%

Europe

     347      337    3 %

Asia Pacific

     666      729    (9 )%
    

  

      

Total

   $ 1,599    $ 1,731    (8 )%
    

  

      

NET REVENUE

                    

Americas

   $ 600    $ 660    (9 )%

Europe

     374      323    16 %

Asia Pacific

     848      692    23 %
    

  

      

Total

   $ 1,822    $ 1,675    9 %
    

  

      
     Twelve Months Ended
October 31,


  

Percent

Inc/(Dec)


 
     2004

   2003

  

ORDERS

                    

Americas

   $ 2,420    $ 2,303    5 %

Europe

     1,463      1,248    17 %

Asia Pacific

     3,114      2,533    23 %
    

  

      

Total

   $ 6,997    $ 6,084    15 %
    

  

      

NET REVENUE

                    

Americas

   $ 2,424      2,347    3 %

Europe

     1,474      1,214    21 %

Asia Pacific

     3,283      2,495    32 %
    

  

      

Total

   $ 7,181    $ 6,056    19 %
    

  

      

 

In general, recorded orders represent firm purchase commitments from our customers with established terms and conditions for products and services that will be delivered within six months.


AGILENT TECHNOLOGIES, INC.

Reconciliation of Segment ROIC

(In millions)

(Unaudited)

 

     Q4 FY04
ATG


    Q4 FY04
SPG


    Q4 FY04
LSCA


    Q4 FY04
TMO


    Q3 FY04
ATG


    Q3 FY04
SPG


    Q3 FY04
LSCA


    Q3 FY04
TMO


    Q4 FY03
ATG


    Q4 FY03
SPG


    Q4 FY03
LSCA


    Q4 FY03
TMO


 

Numerator:

                                                                                                

Segment income (loss) from operations

   $ (7 )   $ 8     $ 58     $ 116     $ 19     $ 33     $ 46     $ 88     $ 45     $ 40     $ 53     $ (11 )

Less:

                                                                                                

Other (income) expense and taxes

     (4 )     (10 )     24       36       6       (11 )     16       24       23       (7 )     16       (11 )
    


 


 


 


 


 


 


 


 


 


 


 


Segment return

     (3 )     18       34       80       13       44       30       64       22       47       37       —    
    


 


 


 


 


 


 


 


 


 


 


 


Segment return annualized

   $ (12 )   $ 72     $ 136     $ 320     $ 52     $ 176     $ 120     $ 256     $ 88     $ 188     $ 148     $ —    
    


 


 


 


 


 


 


 


 


 


 


 


Denominator:

                                                                                                

Segment assets (1)(2)

   $ 718     $ 1,434     $ 725     $ 2,148     $ 766     $ 1,462     $ 704     $ 2,231     $ 804     $ 1,420     $ 680     $ 2,268  

Less:

                                                                                                

Net current liabilities (3)

     117       241       181       414       123       253       172       404       115       289       181       471  
    


 


 


 


 


 


 


 


 


 


 


 


Invested capital

   $ 601     $ 1,193     $ 544     $ 1,734     $ 643     $ 1,209     $ 532     $ 1,827     $ 689     $ 1,131     $ 499     $ 1,797  
    


 


 


 


 


 


 


 


 


 


 


 


Average Invested capital

   $ 622     $ 1,201     $ 538     $ 1,781     $ 676     $ 1,168     $ 521     $ 1,830     $ 666     $ 1,152     $ 490     $ 1,851  

ROIC

     -2 %     6 %     25 %     18 %     8 %     15 %     23 %     14 %     13 %     16 %     30 %     0 %

 

ROIC calculation:(annualized current quarter segment return)/(average of the two most recent quarter-end balances of Segment Invested Capital)


(1) As of Q3 FY04 the invested capital used to calculate ROIC was increased to include allocated corporate net assets. The largest component of the increase for each segment relates to deferred tax assets which were calculated and allocated as if the valuation allowance had not been recorded in Q3 FY03. Prior periods have been restated to reflect this change.
(2) Segment assets consist of inventory, accounts receivable, property plant and equipment, gross goodwill and other intangibles, deferred taxes and allocated corporate assets.
(3) Includes accounts payable, employee compensation and benefits, other accrued liabilities and allocated corporate liabilities.

 

We provide non-GAAP financial information in order to provide meaningful supplemental information regarding our operational performance and to enhance our investors’ overall understanding of our core current financial performance and our prospects for the future. We believe that our investors benefit from seeing our results “through the eyes” of management in addition to the GAAP presentation. Management measures segment and enterprise performance using measures such as those that are disclosed in this release. This information facilitates management’s internal comparisons to the company’s historical operating results and comparisons to competitors’ operating results.

 

Non-GAAP information allows for greater transparency to supplemental information used by management in its financial and operational decision making. Historically, we have reported similar non-GAAP information to our investors and believe that the inclusion of comparative numbers provides consistency in our financial reporting.

 

This information is not in accordance with, or an alternative for, generally accepted accounting principles in the United States. It excludes items, such as restructuring and amortization, that may have a material effect on the company’s net income (loss) and net income (loss) per share calculated in accordance with GAAP. Management monitors these items to ensure that expenses are in line with expectations and that our GAAP results are correctly stated but does not use them to measure the ongoing operating performance of the company. The non-GAAP information we provide may be different from the non-GAAP information provided by other companies.


AGILENT TECHNOLOGIES, INC

RECONCILIATION OF DAYS ON HAND (DOH)

 

(In millions)

 

     Q404

   Q403

   Yr vs. Yr
Change in Days


 

GAAP

                

Costs of Products and Services

   1,042    961       

Net Inventory

   1,026    995       

GAAP Inventory Days

   89    93    (4 )

Non-GAAP

                

Costs of Products and Services

   1,042    961       

Less:

                

Amort of Intangibles

   1    8       

Restructuring

   15    15       

Inventory Charges

   18    —         

Other

   2    —         
    
  
      

Adjusted Costs of Products and Services

   1,006    938       

Net Inventory

   1,026    995       
    
  
      

Non-GAAP Inventory Days

   92    95    (3 )
    
  
      

 

    GAAP DOH Formula:      (Quarter end net inventory x 90 Days)/(Current quarter’s COGS)
    Non-GAAP DOH Formula:      (Quarter-end net inventory x 90 Days)/(Current quarter’s COGS - Inventory Charges - Non-GAAP Adjustments)

 

We provide non-GAAP financial information in order to provide meaningful supplemental information regarding our operational performance and to enhance our investors’ overall understanding of our core current financial performance and our prospects for the future. We believe that our investors benefit from seeing our results “through the eyes” of management in addition to the GAAP presentation. Management measures segment and enterprise performance using measures such as those that are disclosed in this release. This information facilitates management’s internal comparisons to the company’s historical operating results and comparisons to competitors’ operating results.

 

Non-GAAP information allows for greater transparency to supplemental information used by management in its financial and operational decision making. Historically, we have reported similar non-GAAP information to our investors and believe that the inclusion of comparative numbers provides consistency in our financial reporting.

 

This information is not in accordance with, or an alternative for, generally accepted accounting principles in the United States. It excludes items, such as restructuring and amortization, that may have a material effect

 

on the company’s net income (loss) and net income (loss) per share calculated in accordance with GAAP. Management monitors these items to ensure that expenses are in line with expectations and that our GAAP results are correctly stated but does not use them to measure the ongoing operating performance of the company. The non-GAAP information we provide may be different from the non-GAAP information provided by other companies.